Aclarion Inc Ordinary Shares ACON
News
Aclarion Publishes CEO Shareholder Letter Highlighting Continued Scan Volume Growth and Advancing Clinical Program in Third Quarter 2026
Aclarion to Present at the 20th Annual LD Micro Main Event
Aclarion Broadens CLARITY Trial Enrollment Criteria to Accelerate Enrollment
Aclarion Welcomes NYU Langone Health to CLARITY Trial Network, Now Enrolling at Eleven Sites
Aclarion Announces Addition of University of Arizona College of Medicine – Phoenix as CLARITY Trial Site
